Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Outcomes of Hepatocellular Carcinoma involving the Portal Vein Main Trunk and/or the Inferior Vena Cava: Experience From a Multidisciplinary Liver Cancer Clinic.

Cancer medicine·2026

Same author

WE-UNet: A Wavelet-enhanced U-Net framework for radiation dose reduction in chest radiography.

Journal of applied clinical medical physics·2026

Same author

Recent developments and prospects in locoregional therapy of hepatocellular carcinoma.

Abdominal radiology (New York)·2026

Same author

Thyroid Artery Embolization for Benign Thyroid Hyperplasia.

Journal of clinical medicine·2026

Same author

Utility of Yttrium-90 Radioembolization for the Treatment of Fibrolamellar Hepatocellular Carcinoma: A Tertiary Cancer Center Experience.

Journal of hepatocellular carcinoma·2026

Same author

Yttrium-90 Radioembolization Provides Durable Local Control and Definitive Radiation Therapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same journal

Prognostic value of perioperative gamma-glutamyl transferase trajectories in perihilar cholangiocarcinoma: a multicentre retrospective cohort study.

Therapeutic advances in medical oncology·2026

Same journal

Clinical significance of high-density lipoprotein cholesterol and its dynamic change in patients with lymphoma-associated hemophagocytic lymphohistiocytosis.

Therapeutic advances in medical oncology·2026

Same journal

CD39+CD8+ T cell infiltration is associated with clinical outcomes of subsequent immunotherapy in advanced EGFR-mutant non-small cell lung cancer.

Therapeutic advances in medical oncology·2026

Same journal

Dynamics of HER2 status following neoadjuvant systemic therapy in breast cancer: a large single-center cohort analysis.

Therapeutic advances in medical oncology·2026

Same journal

Serum levels of the C-terminal pro-peptide of type V collagen have prognostic potential and are associated with a normal subtype of desmoplasia in a retrospective cohort of patients with esophagogastric cancer.

Therapeutic advances in medical oncology·2026

Same journal

Exploring the molecular classification-based personalized treatment decision-making in FIGO stage I-III endometrial carcinoma after surgery: a population-based real-world study.

Therapeutic advances in medical oncology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 5, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

New frontiers in radioembolization.

Arian Mansur¹, Peiman Habibollahi², Adam Fang³

¹Harvard Medical School, Boston, MA, USA.

Therapeutic Advances in Medical Oncology

|October 7, 2024

Summary

This summary is machine-generated.

Radioembolization uses targeted radiation beads for liver cancer treatment, evolving from palliative care to curative intent, neoadjuvant therapy, and transplant bridging. This therapy is crucial for managing hepatocellular carcinoma and liver metastasis.

Keywords:

dosimetry eye90 holmium radioembolization selective internal radiation therapy

More Related Videos

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Related Experiment Videos

Last Updated: May 5, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Area of Science:

Interventional Radiology
Nuclear Medicine
Oncology

Background:

Radioembolization is a transarterial therapy delivering internal radiation via radionuclide-loaded microspheres.
Its application has expanded beyond palliative care to include curative, neoadjuvant, and bridging therapies for liver conditions.

Purpose of the Study:

To provide a comprehensive overview of radioembolization techniques.
To discuss current challenges and emerging developments in the field.
To highlight advancements in dosimetry, radionuclides, and target tumor applications.

Main Methods:

Review of current literature and clinical practices in radioembolization.
Analysis of evolving techniques for radiation delivery and tumor targeting.
Exploration of new dosimetry methodologies and radionuclide agents.

Main Results:

Radioembolization is increasingly utilized for hepatocellular carcinoma and liver metastasis.
The therapy's role has broadened significantly, offering versatile treatment options.
Novel developments are enhancing precision and expanding the scope of radioembolization.

Conclusions:

Radioembolization is a vital therapeutic option for liver malignancies.
Ongoing advancements promise improved efficacy and wider applicability.
Further research into new techniques and targets will continue to shape its role in oncology.